2 completed, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Withdrawn 1 |
Follow Compliance: new trials by email Literature Review of Compliance trials Research Report on Compliance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use Biotene oral spray - Overactive Bladder, Xerostomia | Phase 4 | Withdrawn | University of Southern California | 2018-08-01 | 2018-07-12 | |
| Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia Omeprazole, Flupentixol-Melitracen(psychological and GI) + Omeprazole, Flupentixol-Melitracen(psychological) + Omeprazole - Dyspepsia, Compliance | Phase 4 | Completed | RenJi Hospital | 262 | 2013-05-01 | 2015-02-23 |
| Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis Raloxifene, Strontium ranelate - Postmenopausal Osteoporosis, Compliance | Phase 4 | Completed | University of Valencia | 80 | 2009-09-01 | 2012-09-03 |
Patient Compliance (3) · Depression (1) · Dyspepsia (1) · Osteoporosis, Postmenopausal (1) · Urinary Bladder, Overactive (1) · Xerostomia (1)
Behavior (3) · Health Behavior (3) · Patient Acceptance of Health Care (3) · Treatment Adherence and Compliance (3) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Behavioral Symptoms (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Lower Urinary Tract Symptoms (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Mouth Diseases (1)
Biotene (1) · Flupenthixol (1) · Omeprazole (1) · Raloxifene Hydrochloride (1) · strontium ranelate (1)
RenJi Hospital (1) · University of Southern California (1) · University of Valencia (1)
China (1) · Spain (1)
Antonio Cano, MD (1) · Christina Dancz (1) · Shengliang Chen (1)
PMID 10435146, PMID 10775736, PMID 15712851, PMID 21532512, PMID 21684773, PMID 25914475